Ipsen at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Ipsen takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 8037. Its program centres on treatment decisions in kidney cancer and neuroendocrine tumours. It looks at how those choices shape each patient's course of care.

OrganizationESMO 2026 Attendance
ipsen.com
Large pharmaExhibitor
French biopharmaceutical company with medicines in oncology, rare disease and neuroscience.
Booth
Exhibiting at Booth 8037
Satellite
Sat Oct 24
18:30–20:00
Ipsen - Treatment decisions that shape the journey in RCC and NETs
Sponsored session · with Gustave Roussy, University Hospital Erlangen
Genitourinary cancersSarcoma, CNS, head & neck and rare cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Ipsen

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction